Condition
Primary CNS Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Primary CNS Tumors clinical trials that are recruiting, at sites in 12 countries (most in Australia (1), Canada (1), Denmark (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 12Countries
All recruiting trials (2)
-
Added tissue or liquid biopsy profiling to guide advanced solid tumor treatment
This study tests how comprehensive genomic profiling from tumor tissue or blood can help tailor treatment decisions for adults with advanced solid tumors or primary CNS cancers at multiple centers.
-
Treatment with repotrectinib for young patients with specific genetic alterations in tumors
This study is testing a new oral medication called repotrectinib to see if it can help young patients with advanced tumors that have certain genetic changes when other treatments haven't worked.
Related topics
Quick answers
How many Primary CNS Tumors clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in Australia (1 trial), Canada (1 trial), Denmark (1 trial), France (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.